Even though only less than 20% of analyzed EC patients (98/527, 18.6%) met the HBOC germline genetic testing criteria, the overall frequencies of PV carriers in BRCA1/BRCA2 were unusually high in contrast to other studies (Fig. 3). This evidence concerns the gene BRCA1 and acquired polycythemia vera.